$2.90+0.01 (+0.26%)
Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States.
Tenon Medical, Inc. in the Healthcare sector is trading at $2.90 with a market capitalization of $2M. Wall Street consensus targets $44.38 (2 analysts), implying a +1431.5% move over the next 12 months. The stock is currently near its 52-week low of $2.40, remaining 84.8% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.28Mβ | $1.38Mβ | $1.48Mβ | $1.17Mβ | $564,000 |
| Gross Profit | $814,000β | $945,000β | $1.02Mβ | $773,000β | $245,000 |
| Operating Income | -$3.35Mβ | -$3.28Mβ | -$2.87Mβ | -$3.39Mβ | -$2.86M |
| Net Income | -$4.05Mβ | -$3.48Mβ | -$2.83Mβ | -$3.34Mβ | -$2.77M |
Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive inferior-posterior approach to the...